Results 261 to 270 of about 82,766 (300)
Some of the next articles are maybe not open access.
The genetics of antiplatelet drug resistance
Clinical Genetics, 2008Platelets have a central role in the development of arterial thrombosis and subsequent cardiovascular events. An appreciation of this complex process has made antiplatelet therapy the cornerstone of cardiovascular disease management. However, numerous patients will experience a recurrent atherothrombotic vascular event despite adequate antiplatelet ...
Fehér, G. +5 more
openaire +3 more sources
Platelet Resistance to Antiplatelet Drugs
Recent Patents on Cardiovascular Drug Discovery, 2009In patients with cardiovascular diseases, platelet aggregation plays an important role in development of cardiovascular events and hence its inhibition is important in prevention and treatment of these events. Antiplatelet therapy is the cornerstone of treatment for patients with acute coronary syndrome and in those who undergo percutaneous coronary ...
Ashwani, Kumar, John, Kao
openaire +2 more sources
Antimicrobial effects of antiplatelet drugs and antimicrobial / antiplatelet drug combinations
2021Duale Antiplättchen-Therapie (DAPT), bestehend aus einem P2Y12-Rezeptor-Inhibitor und Acetylsalicylsäure (Aspirin), stellt den Eckpfeiler der pharmakologischen Behandlung des akuten Koronarsyndroms (ACS) dar. Gegenwärtig gibt es eine wachsende Zahl von Belegen für die antimikrobielle Aktivität von Ticagrelor, einem P2Y12-Inhibitor, aber es ergaben sich
openaire +1 more source
Drugs, 1979
Because platelets are so important in thrombus formation, drugs which inhibit platelet function (the 'antiplatelet drugs') have considerable potential as antithrombotic agents. Among the antiplatelet drugs, only aspirin, sulphinpyrazone, dipyridamole, hydroxychloroquine, and clofibrate have had wide clinical trial.
openaire +2 more sources
Because platelets are so important in thrombus formation, drugs which inhibit platelet function (the 'antiplatelet drugs') have considerable potential as antithrombotic agents. Among the antiplatelet drugs, only aspirin, sulphinpyrazone, dipyridamole, hydroxychloroquine, and clofibrate have had wide clinical trial.
openaire +2 more sources
Nihon rinsho. Japanese journal of clinical medicine, 2014
Antiplatelet therapy is widely used with proven benefit for the prevention of further ischemic complications in patients with coronary heart disease and stroke. Treatment guidelines for acute coronary syndrome and percutaneous coronary intervention now recommend the use of oral antiplatelet agents including clopidogrel in combination with aspirin (dual
openaire +1 more source
Antiplatelet therapy is widely used with proven benefit for the prevention of further ischemic complications in patients with coronary heart disease and stroke. Treatment guidelines for acute coronary syndrome and percutaneous coronary intervention now recommend the use of oral antiplatelet agents including clopidogrel in combination with aspirin (dual
openaire +1 more source
Antiplatelet drugs: Potential therapeutic options for the management of neurodegenerative diseases
Medicinal Research Reviews, 2023Samir Kumar Beura +2 more
exaly
Anticoagulant and antiplatelet drugs
Catheterization and Cardiovascular Interventions, 2001openaire +2 more sources